Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Contralateral gliosis as a function of degeneration stressor in the optic nerve.
Author Affiliations & Notes
  • Jack Serkiz
    Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States
  • Joanne Konstantopolous
    Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States
  • Marco Cimino
    European Brain Research Institute, Rome, Lazio, Italy
  • marco feligioni
    European Brain Research Institute, Rome, Lazio, Italy
  • Rebecca M Sappington
    Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States
  • Footnotes
    Commercial Relationships   Jack Serkiz None; Joanne Konstantopolous None; Marco Cimino None; marco feligioni None; Rebecca Sappington None
  • Footnotes
    Support  BrightFocus Foundation, Inc. - G2022015S and National Eye Institute - RO1EY020496
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6766. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jack Serkiz, Joanne Konstantopolous, Marco Cimino, marco feligioni, Rebecca M Sappington; Contralateral gliosis as a function of degeneration stressor in the optic nerve.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6766.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Previous studies indicate the presence of gliotic and neuroinflammatory changes in the unaffected optic nerve of unilateral injury models. The purpose of this study was to systematically examine the contribution of injury, IOP, and excitotoxicity stressors to this contralateral gliotic phenotype in mice with unilateral retinal ganglion cell (RGC) degeneration.

Methods : Using a dual model approach, we compared IOP-dependent gliosis and IOP-independent gliosis in the microbead model of ocular hypertension and the NMDA model of excitotoxicity. To delineate the contributions of ocular hypertension and ocular injury to contralateral gliosis in the optic nerve, we performed three, unilateral variations of the microbead occlusion model: sham injection, saline injection and microbead injection. Reactive gliosis was assessed by immunohistochemical approaches and quantitative digital analysis of microglia and astrocyte reactivity, including hypertrophy, ramification, and density. Gliosis measures were benchmarked to the neurodegeneration profile of each optic nerve as well as outcomes of visual function, including electroretinogram (ERG) and flash visual-evoked potentials (F-VEP).

Results : RGC degeneration was observed at both structural and functional levels of affected eyes following 4 weeks of either microbead-induced IOP elevation or NMDA excitotoxicity. Attenuation of ERG and F-VEP amplitudes were detected in microbead-injected and NMDA-injected eyes (p<0.05). However, visual function contralateral to these stressors remained unchanged from naïve levels (p>0.05). Similar outcomes were noted for RGC and axon pathology, where only microbead-injected and NMDA-injected eyes exhibited changes in degenerative axon profiles (p<0.05). In contrast, quantification of percent area coverage (hypertrophy/ramification), nearest neighbor analysis (migration), and density measurements indicated increased microglia reactivity (p<0.05) and astrocyte remodeling (p<0.05) in both affected and contralateral optic nerves. Contralateral gliosis was not noted in optic nerves control, sham, and saline-injected animals (p>0.05).

Conclusions : Our results suggest that contralateral gliosis is not a generalized response to ocular stress or injury, but coincides with RGC degeneration. Furthermore, contralateral gliosis is apparent in both microglia and astrocyte populations, similar to the gliosis response in nerve with active axon degeneration.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×